TECH
HEALTHCAREBio-Techne Corp
$47.41-9.28 (-16.36%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving TECH Today?
No stock-specific AI insight has been generated for TECH yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$45.12$72.06
$47.41
Fundamentals
Market Cap$7.4B
P/E Ratio89.4
EPS$0.53
Dividend Yield—
Dividend / Share—
ROE0.0%
Profit Margin0.1%
Debt / Equity—
Trading
Volume11.9M
Avg Volume (10D)—
Shares Outstanding156.5M
TECH News
29 articles- Principal Financial Group Inc. Has $41.37 Million Stock Position in Bio-Techne Corp $TECHMarketBeat·May 9, 2026
- Why Bio-Techne Is Dropping 5.9%: Citigroup Maintains BuyAlphaStreet·May 8, 2026
- Analyst recommendations: Airbnb , Citigroup , The Walt Disney Company , Block, Cloudflare...marketscreener.com·May 8, 2026
- Deutsche Bank Adjusts Bio-Techne Price Target to $66 From $75, Maintains Buy Ratingwww.marketscreener.com·May 8, 2026
- April McClain Delaney Makes Significant Trades in Bio-Techne Corp, C.H. Robinson Worldwide, and Transdigm GroupInvesting.com Canada·May 7, 2026
- Bio-Techne (TECH) SVP exercises 8,400 options, 7,055 shares withheld for taxesStock Titan·May 7, 2026
- CFO at Bio-Techne (TECH) exercises 62,000 options and settles taxes in sharesStock Titan·May 7, 2026
- Citigroup Issues Pessimistic Forecast for Bio-Techne (NASDAQ:TECH) Stock PriceMarketBeat·May 7, 2026
- Wells Fargo & Company Cuts Bio-Techne (NASDAQ:TECH) Price Target to $62.00MarketBeat·May 7, 2026
- Bio-Techne Q3 Earnings Call HighlightsMarketbeat·May 7, 2026
- Why Bio-Techne (TECH) Is Up 5.9% After Profits Rose Despite Slightly Lower Sales – And What's NextYahoo Finance·May 6, 2026
- Bio-Techne Corporation Q3 2026 Earnings Call SummaryMoby·May 6, 2026
- Bio-Techne (TECH) Q3 2026 Earnings TranscriptMotley Fool·May 6, 2026
- Bio-Techne (TECH) Q1 2025 Earnings TranscriptMotley Fool·May 6, 2026
- TECH Stock Falls on Q3 Earnings & Revenue Miss, Operating Margin UpYahoo Finance·May 6, 2026
- Bio-Techne (NASDAQ:TECH) Reports Sales Below Analyst Estimates In Q1 CY2026 EarningsYahoo Finance·May 6, 2026
- Techne (TECH) Misses Q3 Earnings and Revenue EstimatesYahoo Finance·May 6, 2026
- Bio-Techne Releases Third Quarter Fiscal 2026 ResultsYahoo Finance·May 6, 2026
- Bio-Techne Declares DividendYahoo Finance·May 6, 2026
- Precision BioSciences (DTIL) Reports Q1 Loss, Tops Revenue EstimatesYahoo Finance·May 5, 2026
- Bio-Techne to Present at the Bank of America Securities 2026 Global Healthcare ConferenceYahoo Finance·May 4, 2026
- Bio-Techne's Q3 Earnings on Deck: What's in Store for the Stock?Yahoo Finance·Apr 29, 2026
- 3 Small-Cap Stocks That Fall ShortYahoo Finance·Apr 22, 2026
- 1 Profitable Stock to Target This Week and 2 We Brush OffYahoo Finance·Apr 22, 2026
- 1 S&P 500 Stock to Own for Decades and 2 We QuestionYahoo Finance·Apr 20, 2026
- Bio-Techne Reorganizes Brand To Link Research Spatial And Diagnostics WorkflowsYahoo Finance·Apr 20, 2026
- Revvity, Bio-Techne, Corcept, Supernus Pharmaceuticals, and Phibro Animal Health Shares Skyrocket, What You Need To KnowYahoo Finance·Apr 18, 2026
- What to Expect From Bio-Techne's Q3 2026 Earnings ReportBarchart·Apr 17, 2026
- Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater ClarityYahoo Finance·Apr 16, 2026
All 29 articles loaded
Price Data
Open$56.68
Previous Close$56.68
Day High$56.68
Day Low$45.12
52 Week High$72.06
52 Week Low$45.12
52-Week Range
$45.12$72.06
$47.41
Fundamentals
Market Cap$7.4B
P/E Ratio89.4
EPS$0.53
Dividend Yield—
Dividend / Share—
ROE0.0%
Profit Margin0.1%
Debt / Equity—
Trading
Volume11.9M
Avg Volume (10D)—
Shares Outstanding156.5M
About Bio-Techne Corp
Bio-Techne Corporation develops, manufactures, and sells life science reagents, instruments, and services for the global clinical diagnostic and research markets. The company is headquartered in Minneapolis, Minnesota.
HEALTHCAREBIOTECHNOLOGY
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICBIOTECHNOLOGY
CIK—
Composite FIGI—
Share Class FIGI—